Comparative Effectiveness of Mepolizumab and Omalizumab in Severe Asthma: An Indirect Comparison

Included studies were double-blind randomized controlled clinical trials (RCTs) >=12 weeks' in duration among severe asthma patients >=12 years old, with a documented exacerbation history and receiving high-dose inhaled corticosteroids plus >=1 additional controller.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB82-AB82
Main Authors: Stynes, Gillian, Cockle, Sarah, Gunsoy, Necdet, PhD, Park, Daniel C, Wex, Jaro, Wilson, Jenny, Bradford, Eric, MD, Albers, Frank C., MD, PhD, Alfonso-Cristancho, Rafael, MD, PhD, MSc
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Included studies were double-blind randomized controlled clinical trials (RCTs) >=12 weeks' in duration among severe asthma patients >=12 years old, with a documented exacerbation history and receiving high-dose inhaled corticosteroids plus >=1 additional controller.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2015.12.397